Newsroom

Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North Texas The START Center for Cancer Research (“START”), the world’s largest community-based network of clinical trial sites specializing in early-phase oncology trials, today announced the appointment of Salwan Al Mutar, MD, […]

Partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research The START Center for Cancer Research (“START”), the world’s largest community-based network of clinical trial sites specializing in early-phase oncology trials, today announced a strategic partnership with Trialing, a platform dedicated to connecting physicians and

Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions. The START Center for Cancer Research (“START”), today announced the appointment of Frank Smith, PhD, MBA, as President of XenoSTART, its preclinical business unit. In this role, Dr. Smith will oversee XenoSTART’s operations,

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices The START Center for Cancer Research (“START”), the world’s largest community-based network specializing in early-phase oncology trials, today announced the appointment of Navid Hafez, MD, MPH, as Director of Clinical

The first START site in New York launches new strategic partnership to provide cutting-edge cancer research Northwell Health and The START Center for Cancer Research held a ceremonial ribbon-cutting to unveil Northwell-START New York-Long Island, which reflects a $5.7 million investment for a 10,000-square foot, state-of-the-art early-phase cancer clinical trial center. Located at Northwell’s outpatient

New START site at HM Montepríncipe University Hospital offers clinical trial access for children with cancer The START Center for Cancer Research (“START”), the world’s largest community-based network specializing in early-phase oncology clinical trials, together with HM Hospitales, announces the launch of a pediatric onco-hematology clinical research unit at HM Montepríncipe University Hospital in Madrid.

Expanded partnership positions XenoSTART and Minerva Imaging at the forefront of radiopharmaceuticals — one of the fastest-growing areas in oncology drug development. The START Center for Cancer Research (“START”), its preclinical division XenoSTART, and Minerva Imaging today announced an expansion of their decade-long partnership to establish the industry’s most comprehensive integrated platform for radiopharmaceutical drug

START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem The START Center for Cancer Research (“START”), the leading global community-based early-phase oncology research network, today announced a strategic partnership with Advarra, the premier